The Quartet® is a hardware-software system that allows a causal connection between neuronal short and long range circuitry and disease phenotype. The company uses advanced machine learning and quantum machine learning techniques to enhance neurodegenerative, motor and mood disorder drug development. Their initial target market is neuroscience research, but they are also pursuing its use in commercial drug development for the central nervous system.